These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 416147)

  • 41. Meningococcal meningitis.
    Sohal AS; Rao VR
    Br Med J (Clin Res Ed); 1988 May; 296(6634):1471-2. PubMed ID: 3132305
    [No Abstract]   [Full Text] [Related]  

  • 42. Invasive meningococcal disease: secondary spread in a day-care center.
    Leggiadro RJ; Baddour LM; Frasch CE; LaFrain JF; Gaia SM; Thomas JA
    South Med J; 1989 Apr; 82(4):511-3. PubMed ID: 2495572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of ciprofloxacin on carrier rate of Neisseria meningitidis in army recruits in Finland.
    Renkonen OV; Sivonen A; Visakorpi R
    Antimicrob Agents Chemother; 1987 Jun; 31(6):962-3. PubMed ID: 3113331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of rifampin and minocycline on meningococcal carrier rates.
    Guttler RB; Counts GW; Avent CK; Beaty HN
    J Infect Dis; 1971 Aug; 124(2):199-205. PubMed ID: 4942060
    [No Abstract]   [Full Text] [Related]  

  • 45. [The prevalence of nasopharyngeal Neisseria meningitidis carriage, serogroup distribution, and antibiotic resistance among healthy children in Cankaya municipality schools of Ankara province].
    Ercis S; Köseoğlu O; Salmanzadeh-Ahrabi S; Ercis M; Akin L; Hasçelik C
    Mikrobiyol Bul; 2005 Oct; 39(4):411-20. PubMed ID: 16544542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective minocycline and rifampin treatment of group C meningococcal carriers in a new naval recruit camp.
    Devine LF; Springer GL; Frazier WE; Rhode SL; Pierce WE; Johnson DP; Peckinpaugh RO
    Am J Med Sci; 1972 Feb; 263(2):79-93. PubMed ID: 4622855
    [No Abstract]   [Full Text] [Related]  

  • 47. Serogroups and antibiotic susceptibility patterns of Neisseria meningitidis isolated from army recruits in a training camp.
    Rohani MY; Ahmad Afkhar F; Amir MA; Muhd Amir K; Sahura H; Fairuz A; Norazah A; Monalisa AR; Tay AW; Azizah M; Norzarila Z; Lim KE
    Malays J Pathol; 2007 Dec; 29(2):91-4. PubMed ID: 19108400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of severe staphylococcal infections with a rifampicin-minocycline association.
    Clumeck N; Marcelis L; Amiri-Lamraski MH; Gordts B
    J Antimicrob Chemother; 1984 Jun; 13 Suppl C():17-22. PubMed ID: 6469887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meningococcal infection: evidence for school transmission.
    Wall R; Wilson J; MacArdle B; Vellani Z
    J Infect; 1991 Sep; 23(2):155-9. PubMed ID: 1753114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meningococcaemia: current concepts in prophylaxis.
    Ball AP
    J Infect; 1980 Dec; 2(4):316-9. PubMed ID: 6821087
    [No Abstract]   [Full Text] [Related]  

  • 51. [Persistence and transmission of Neisseria meningitidis in a family with a case of fatal infection].
    Sáez Nieto JA; Marín M; Casanovas A; Marcos C
    Enferm Infecc Microbiol Clin; 1990 Apr; 8(4):222-4. PubMed ID: 2128608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sulphonamide-resistant meningococci after sulphonamide prophylaxis among vaval recruits in Norway.
    Holten E; Vaage L; Neess C; Midtvedt T; Jyssum K
    Scand J Infect Dis; 1969; 1(3):185-9. PubMed ID: 4999685
    [No Abstract]   [Full Text] [Related]  

  • 53. Bacterial meningitis. Some aspects of diagnosis and treatment.
    Hambleton G; Davies PA
    Arch Dis Child; 1975 Sep; 50(9):674-84. PubMed ID: 242276
    [No Abstract]   [Full Text] [Related]  

  • 54. Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers.
    Devine LF; Pollard RB; Krumpe PE; Hoy ES; Mammen RE; Miller CH; Peckinpaugh RO
    Am J Epidemiol; 1973 Jun; 97(6):394-401. PubMed ID: 4197420
    [No Abstract]   [Full Text] [Related]  

  • 55. [Chemoprevention in meningococcal meningitis. A health problem or a social response?].
    Garrido Morales P; Domínguez García A; Pumarola Busquets F
    Med Clin (Barc); 1985 Oct; 85(10):418-22. PubMed ID: 3935888
    [No Abstract]   [Full Text] [Related]  

  • 56. Rifampin-resistant meningococcal infection in a patient given rifampin chemoprophylaxis.
    Berkey P; Rolston K; Zukiwski A; Gooch G; Bodey GP
    Am J Infect Control; 1988 Dec; 16(6):250-2. PubMed ID: 3144922
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of minocycline and ampicillin in gonococcal urethritis.
    Waugh MA; Cooke EM; Nehaul BB; Brayson J
    Br J Vener Dis; 1979 Dec; 55(6):411-4. PubMed ID: 393363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Secondary cases of meningococcal disease in The Netherlands, 1989-1990; a reappraisal of chemoprophylaxis].
    Scholten RJ; Bijlmer HA; Dankert J; Valkenburg HA
    Ned Tijdschr Geneeskd; 1993 Jul; 137(30):1505-8. PubMed ID: 8366938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Meningococcal colonization and infection in children and their household contacts.
    Marks MI; Frasch CE; Shapera RM
    Am J Epidemiol; 1979 May; 109(5):563-71. PubMed ID: 110143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemoprophylaxis of meningitis.
    Jones DM
    Trans R Soc Trop Med Hyg; 1991; 85 Suppl 1():44-5. PubMed ID: 1803697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.